Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krzysztof Zak

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|February 10, 2010
[Pancytopenia after methotrexate treatment]Krzysztof Zak, Andrzej Prystupa, Andrzej Dybała, et al.
Expert Opinion on Therapeutic Patents|February 5, 2013
Mdm2 and MdmX inhibitors for the treatment of cancer: a patent review (2011-present)Krzysztof Zak, Aleksandra Pecak, Barbara Rys, et al.
Genes|October 27, 2022
Population Genetic Data of 30 Insertion-Deletion Markers in the Polish PopulationMonica Abreu-Glowacka, Witold Pepinski, Eliza Michalak, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|February 10, 2010
[Pancytopenia after methotrexate treatment]Krzysztof Zak, Andrzej Prystupa, Andrzej Dybała, et al.
Expert Opinion on Therapeutic Patents|February 5, 2013
Mdm2 and MdmX inhibitors for the treatment of cancer: a patent review (2011-present)Krzysztof Zak, Aleksandra Pecak, Barbara Rys, et al.
Genes|October 27, 2022
Population Genetic Data of 30 Insertion-Deletion Markers in the Polish PopulationMonica Abreu-Glowacka, Witold Pepinski, Eliza Michalak, et al.
Pageof 1